pharmtrace klinische Entwicklung GmbH Our company, founded in 2006, is a clinical CRO specialized in the integration of imaging into drug development programs. We provide a single point access to a unique combination of expertise in medical imaging, diagnostics and drug development. We have access to a broad network of imaging centers throughout Europe, and a pool of expert radiologists and nuclear medicine physicians for both interim and final blinded image reviews. Our experts know how to design the most appropriate clinical protocols to maximize the power of diagnostics and medical imaging in drug development. They can also take care of imaging center identification, evaluation, qualification, ongoing monitoring and quality control through to image collection, storage, and blinded reads. In addition, we provide all services of a clinical CRO including monitoring, CRF design, data management, statistics, and reporting. pharmtrace's reputation and development is based upon an uncompromising focus on quality and continuous improvement to produce “clean” high quality data and images in multicenter clinical trials.